Top Markets
#1 DogBull DogBull +54.88%
#2 Siren Siren +31.44%
#3 OriginTrail OriginTrail +17.48%
#4 Yield Basis Yield Basis +10.34%
#5 龙虾 (Lobster) 龙虾 (Lobster) +8.85%
#6 MetYa MetYa +8.10%
#7 LayerZero LayerZero +7.76%
#8 COTI COTI +7.55%
#9 Stargate Finance Stargate Finance +7.55%
#10 Cysic Cysic +7.12%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rank in Stocks #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Share Price
$0.3479
Last synced: 2024-08-21
Market Cap
$94.92M
Change (1 day)
0.64%
Change (1 year)
0.00%
Country
US
Trade Asensus Surgical, Inc. (ASXC)

Category

Healthcare
Revenue for Asensus Surgical, Inc. (ASXC)
Revenue in Jun 2024 TTM: $9.85M
According to Asensus Surgical, Inc. latest financial reports the company's current revenue (TTM) is $9.85M. In 2022 the company made a revenue of $7.09M a decrease compared to the revenue in the year 2021 that was $8.23M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Asensus Surgical, Inc. from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $9.85M 14.84%
2023 $8.58M 21.02%
2022 $7.09M -13.91%
2021 $8.23M 159.28%
2020 $3.18M -62.78%
2019 $8.53M -64.60%
2018 $24.10M 238.94%
2017 $7.11M 368.14%
2016 $1.52M 0.00%
2015 0.00 -100.00%
2014 $401.00K -71.98%
2013 $1.43M -32.34%
2012 $2.12M 0.00%
2011 0.00 -100.00%
2010 $-29.00 0.00%
2009 0.00 0.00%
2008 0.00 -100.00%
2007 $-135.00K 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $231.00K -98.04%
2002 $11.77M -42.34%
2001 $20.42M -21.40%
2000 $25.97M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 472,844.16%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 262,204.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 360,143.65%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 213,057.36%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE